Idorsia Ltd (IDRSF) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-26 14:17:47 ET
Idorsia Ltd (IDRSF) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST
Company Participants
Srishti Gupta - CEO & Executive Director
Arno Groenewoud - Executive VP & CFO
Conference Call Participants
Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division
Joris Zimmermann - Octavian AG, Research Division
Niall Alexander - Deutsche Bank AG, Research Division
...
Read the full article on Seeking Alpha
For further details see:
Idorsia Ltd (IDRSF) Q4 2025 Earnings Call Transcript
Idorsia Ltd Registered Shares
NASDAQ: IDRSF
IDRSF Trading
0.0% G/L:
$5.16 Last:
1,502 Volume:
$5.16 Open:
IDRSF Latest News
January 05, 2026 11:45:00 am
Idorsia's daridorexant in women during menopausal transition age with insomnia
December 10, 2025 01:00:00 am
New Hypertension publication underscores aprocitentan's potential in managing hypertension patients with CKD
November 10, 2025 11:45:00 am
Idorsia's aprocitentan improved key prognostic indicators in patients with difficult-to-control hypertension
November 05, 2025 11:45:00 am
Idorsia to present new aprocitentan insights at ASN Kidney Week & AHA Scientific Sessions
